MSH|^~\&|SUT-APP|OFM|IIP-IIS-APP|IIP|20240405131011-0500||VXU^V04^VXU_V04|IIP-Transmit-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|Oregon Family Medicine|Immunization Integration Program
PID|1||1111^^^IIP-MPI-1^MR||Duncan^Lance^Gaige^Jr.^^^L|King^^^^^^M|20240215|M||1002-5^American Indian or Alaska Native^CDCREC|749 Evergreen Ter.^Unit A^Springfield^OR^97477^USA^P||^PRN^CP^^^541^5551111~^NET^X.400^IIPMP@gmail.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||02^Reminder/recall - any method^HL70215|N|20240405|||A|20240126|20240405
NK1|1|Duncan^Ingrid^Stacy^^^^L|MTH^Mother^HL70063|749 Evergreen Ter.^Unit A^Springfield^OR^97477^USA^P|^PRN^CP^^^541^5551111~^NET^X.400^IIPMP@gmail.com
NK1|2|Duncan^Simon^Isaiah^Sr.^^^L|FTH^Father^HL70063|749 Evergreen Ter.^Unit A^Springfield^OR^97477^USA^P|^PRN^CP^^^541^5551233
ORC|RE|1111^OFM|2222^OFM|||||||7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN||654^Bradshaw^Ramon^Michael^^^^^OFM-PI-1^L^^^MD|||||197028^Oregon Family Medicine^HL70362
RXA|0|1|20240405||58160-0811-43^PEDIARIX^NDC^110^DTaP-Hep B-IPV^CVX|0.5|mL^mL^UCUM||00^New immunization record^NIP001|7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN|^^^OFM||||IIPVAXN01|20290927|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^INTRAMUSCULAR^NCIT|LVL^Left Vastus Lateralis^HL70163
OBX|1|CE|30963-3^Vaccine funding source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20240405
OBX|2|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20240405|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|3|CE|69764-9^Document type^LN|3|253088698300026411230724^Multi Pediatric Vaccines VIS - 07/24/2023^cdcgs1vis||||||F|||20240405
OBX|4|DT|29769-7^Date Vaccine Information Statement Presented^LN|3|20240405||||||F|||20240405
ORC|RE|1112^OFM|2223^OFM|||||||7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN||654^Bradshaw^Ramon^Michael^^^^^OFM-PI-1^L^^^MD|||||197028^Oregon Family Medicine^HL70362
RXA|0|1|20240405||49281-0547-58^ActHIB^NDC^48^ActHIB^CVX|0.5|mL^mL^UCUM||00^New immunization record^NIP001|7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN|^^^OFM||||IIPVAXN05|20290927|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^INTRAMUSCULAR^NCIT|RVL^Right Vastus Lateralis^HL70163
OBX|1|CE|30963-3^Vaccine funding source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20240405
OBX|2|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20240405|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|3|CE|69764-9^Document type^LN|3|253088698300006611210806^Haemophilus Influenzae type b (Hib) Vaccine VIS - 08/06/2021^cdcgs1vis||||||F|||20240405
OBX|4|DT|29769-7^Date Vaccine Information Statement Presented^LN|3|20240405||||||F|||20240405
ORC|RE|1113^OFM|2224^OFM|||||||7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN||654^Bradshaw^Ramon^Michael^^^^^OFM-PI-1^L^^^MD|||||197028^Oregon Family Medicine^HL70362
RXA|0|1|20240405||58160-0740-02^Rotarix^NDC^119^rotavirus, monovalent^CVX|1|mL^mL^UCUM||00^New immunization record^NIP001|7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN|^^^OFM||||IIPVAXN07|20290927|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C38288^ORAL^NCIT
OBX|1|CE|30963-3^Vaccine funding source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20240405
OBX|2|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20240405|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|3|CE|69764-9^Document type^LN|3|253088698300019611211015^Rotavirus Vaccine VIS - 10/15/2021^cdcgs1vis||||||F|||20240405
OBX|4|DT|29769-7^Date Vaccine Information Statement Presented^LN|3|20240405||||||F|||20240405
ORC|RE|1114^OFM|2225^OFM|||||||7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN||654^Bradshaw^Ramon^Michael^^^^^OFM-PI-1^L^^^MD|||||197028^Oregon Family Medicine^HL70362
RXA|0|1|20240405||00005-2000-01^Prevnar 20^NDC^216^Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF^CVX|0.5|mL^mL^UCUM||00^New immunization record^NIP001|7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN|^^^OFM||||LLBUAYMO68|20290927|PMC^sanofi pasteur^MVX|||CP|A
RXR|C28161^INTRAMUSCULAR^NCIT|LD^Left Deltoid^HL70163
OBX|1|CE|30963-3^Vaccine funding source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20240405
OBX|2|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20240405|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|3|CE|69764-9^Document type^LN|3|253088698300049311230512^Pneumococcal Conjugate Vaccine (PCV13_PCV15_PCV20) VIS - 05/12/2023^cdcgs1vis||||||F|||20240405
OBX|4|DT|29769-7^Date Vaccine Information Statement Presented^LN|3|20240405||||||F|||20240405